Filter posts

Perspective on Market Valuation for Biotech Drug Developers

Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% …

Boosting Investment in Biotech

The President’s Council on Jobs and Competitiveness issued an interim report with suggestions to increase …

BayBio Announces Lifetime Achievement DiNA Award Recipient

Dr. Michael Hunkapiller has been named BayBio’s 2011 Lifetime Achievement DiNA Award recipient. He will …

BIO's New Personalized Medicine and Diagnostics Working Group

The Biotechnology Industry Organization (BIO) represents a diverse portfolio of companies throughout the continuum of …

Biotechnology Delivers Medical Discoveries to Benefit Women Facing Breast Cancer

By Marc S. Hurlbert, Ph.D., Executive Director, Avon Foundation Breast Cancer Crusade The field of breast …

Increasing Partnering at BIO

Mike May from Biotech Tallies writes: At the 2011 BIO International Convention, the number of …

If Politics Trumps Science, Businesses Will Leave the U.S.

The Anchorage Daily News ran an editorial authored by California Farmer and Alaska fisherman Ted …

National Academies Rehashes Controversies Over RFS

The National Academies this week released a Congressionally mandated study estimating the potential economic and …

Incentivizing Biotech Growth; States and Regions Look to Stand Out from the Crowd

The United States’ prolonged economic woes have drastically impacted state budgets, causing across-the-board program cuts …

KORUS and BIO's New Senior Vice President for International Affairs

Earlier this week, Joseph Damond joined BIO as Senior Vice President of International Affairs.  He …